9 METERS BIOPHARMA, INC. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two in USD from Q1 2019 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
9 Meters Biopharma, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two history and growth rate from Q1 2019 to Q1 2023.
  • 9 Meters Biopharma, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Two for the quarter ending March 31, 2023 was $54K, unchanged year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Two, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Two, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 $54K $0 0% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $54K -$18K -25% Dec 31, 2022 10-K 2023-03-28
Q3 2022 $54K -$18K -25% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $54K -$18K -25% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $54K -$18K -25% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $72K $0 0% Dec 31, 2021 10-K 2022-03-23
Q3 2021 $72K $0 0% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $72K Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $72K Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $72K Dec 31, 2020 10-K 2021-03-22
Q3 2020 $72K +$27K +60% Sep 30, 2020 10-Q 2020-11-09
Q3 2019 $45K Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $45K Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $45K Mar 31, 2019 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.